Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Abstract

Among patients with a recent myocardial infarction, colchicine at a dose of 0.5 mg daily led to a significantly lower risk of ischemic cardiovascular events than placebo. (Funded by the Government of Quebec and others; COLCOT ClinicalTrials.gov number, NCT02551094.).

Keywords

ColchicineGoutMedicinePericarditisMyocardial infarctionInflammationPharmacologyInternal medicineCardiology

Affiliated Institutions

Related Publications

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

R B Sleight , Peter Sleight , Sarah Parish +3 more

17,187 patients entering 417 hospitals up to 24 hours (median 5 hours) after the onset of suspected acute myocardial infarction were randomised, with placebo control, between: (...

1988 PubMed 2873 citations

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

Stephen D. Wiviott , Itamar Raz , Marc P. Bonaca +17 more

In patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease, treatment with dapagliflozin did not result in a higher or lower rate of MAC...

2018 New England Journal of Medicine 5890 citations

Update on prevention, diagnosis, and treatment of chronic hepatitis B

Norah A. Terrault , Anna S. Lok , Brian J. McMahon +6 more

Potential conflict of interest: Dr. Hwang received grants from Merck and Gilead. Dr. Chang advises Arbutus. Dr. Lok received grants from Gilead and Bristol‐Myers Squibb. Dr. Jon...

2018 Hepatology 4007 citations

Publication Info

Year: 2019
Type: article
Volume: 381
Issue: 26
Pages: 2497-2505
Citations: 2651
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2651

OpenAlex

Cite This

APA Style

                            
                                
                                    Jean‐Claude Tardif, 
                                
                                    Simon Kouz, 
                                
                                    David D. Waters
                                
                                et al.
                            
                            (2019). 
                            Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. 
                            New England Journal of Medicine
                            , 381
                            (26)
                            , 2497-2505.
                            https://doi.org/10.1056/nejmoa1912388
                        

Identifiers

DOI: 10.1056/nejmoa1912388